| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 3.74B | 3.36B | 3.17B | 2.83B | 2.96B |
| Gross Profit | 2.08B | 1.80B | 1.70B | 1.38B | 1.55B |
| EBITDA | 898.82M | 719.12M | 696.64M | 464.09M | 627.01M |
| Net Income | 596.97M | 408.00M | 404.10M | 220.46M | 360.82M |
Balance Sheet | |||||
| Total Assets | 4.54B | 4.07B | 3.95B | 3.54B | 3.66B |
| Cash, Cash Equivalents and Short-Term Investments | 767.24M | 816.83M | 697.69M | 447.72M | 638.00M |
| Total Debt | 654.11M | 924.22M | 852.20M | 788.19M | 833.09M |
| Total Liabilities | 1.24B | 1.35B | 1.31B | 1.21B | 1.30B |
| Stockholders Equity | 3.29B | 2.72B | 2.63B | 2.32B | 2.35B |
Cash Flow | |||||
| Free Cash Flow | 691.12M | 379.37M | 416.04M | 53.36M | 369.27M |
| Operating Cash Flow | 763.10M | 521.19M | 575.76M | 238.72M | 510.72M |
| Investing Cash Flow | -278.13M | -145.47M | -154.96M | -227.55M | -142.65M |
| Financing Cash Flow | -575.66M | -227.70M | -173.64M | -201.79M | -452.12M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | HK$5.56B | 4.00 | 16.76% | 3.65% | 11.07% | 48.01% | |
74 Outperform | HK$1.75B | 19.04 | 3.68% | 7.46% | 7.11% | -36.08% | |
72 Outperform | HK$25.95B | 20.07 | 21.02% | 0.63% | 6.10% | 16.67% | |
69 Neutral | HK$8.18B | 20.75 | 11.20% | ― | 25.24% | 7.29% | |
66 Neutral | HK$15.53B | 45.44 | 4.03% | ― | ― | ― | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |